GABA-P 50 mg (Capsule)
Unit Price: ৳ 14.00 (3 x 10: ৳ 420.00)
Strip Price: ৳ 140.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Pregabalin |
| Company | Renata limited |
| Also available as |
Title
- GABA-P 50 mg Capsule
Categories
- Neurological Medication
- Pain Management
- Anticonvulsant
- Anti-epileptic
Description
- GABA-P is indicated for Neuropathic pain associated with diabetic peripheral neuropathy (DPN), Postherpetic neuralgia (PHN), Fibromyalgia, Neuropathic pain associated with spinal cord injury, and Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older.
Dosage
- Maximum recommended dose of Pregabalin is 100 mg three times a day (300 mg/day) in patients with creatinine clearance of at least 60 ml/min for DPN.
- Recommended dose of Pregabalin is 75 to 150 mg two times a day or 50 to 100 mg three times a day (150 to 300 mg/day) in patients with creatinine clearance of at least 60 ml/min for PHN.
- Recommended dose of Pregabalin for the management of fibromyalgia is 300 to 450 mg/day.
- Recommended dose range of Pregabalin for neuropathic pain associated with spinal cord injury is 150 to 600 mg/day.
Administration
- Pregabalin is taken orally, with or without food. Pregabalin CR tablet should be administered after an evening meal.
Side Effects
- Common side effects in adults include dizziness, somnolence, dry mouth, edema, blurred vision, weight gain, and thinking abnormality.
- Most common side effects in pediatric patients for the treatment of partial onset seizures are increased weight and increased appetite.
Pregnancy & Lactation
- No adequate and well-controlled studies with pregabalin in pregnant women. Small amounts of pregabalin have been detected in the milk of lactating women. Breastfeeding is not recommended during treatment with pregabalin.
Precautions & Warnings
- Angioedema can occur and may be associated with life-threatening respiratory compromise requiring emergency treatment. GABA-P should be discontinued immediately in these cases.
- GABA-P may cause dizziness, somnolence, and impair patients' ability to drive or operate machinery.
- Increased seizure frequency or other adverse reactions may occur if GABA-P is rapidly discontinued. GABA-P should be withdrawn gradually over a minimum of 1 week.
Storage Conditions
- Keep in a cool & dry place (below 30°C), protected from light & moisture. Keep out of the reach of children.
Chemical Structure
- Molecular Formula: C8H17NO2
Drug Classes
- Adjunct anti-epileptic drugs
- Primary anti-epileptic drugs
Commonly Asked Questions
- What is GABA-P 50 mg Capsule? - GABA-P 50 mg Capsule is an anticonvulsant and is considered to be the first-line of treatment for neurotic pain, shingles, seizures, and fibromyalgia.
- How long do I need to use GABA-P 50 mg Capsule before I see improvement in my condition? - GABA-P 50 mg Capsule is to be taken till the time you see an improvement in your health conditions.
- At what frequency do I need to use GABA-P 50 mg Capsule? - GABA-P 50 mg Capsule should be taken in the dosage as prescribed by the doctor.
- Should I use GABA-P 50 mg Capsule empty stomach, before food or after food? - GABA-P 50 mg Capsule should be taken after food in a prescribed dosage.
- What are the instructions for the storage and disposal of GABA-P 50 mg Capsule? - GABA-P 50 mg Capsule should be kept in a cool dry place and in its original packaging. Make sure this medication remains unreachable to children and pets.
Interaction
- Drug interaction with medication: GABA-P is unlikely to be involved in significant pharmacokinetic drug interactions.
- Drug interaction with food and others: Not applicable.
Contraindications
- Pregabalin is contraindicated in patients with known hypersensitivity to Pregabalin or any of its components.
Use in Special Populations
- Safety and effectiveness in pediatric patients have not been established for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, neuropathic pain associated with spinal cord injury and fibromyalgia.
- Safety and effectiveness of GABA-P extended-release tablet in pediatric patients have not been established.
Overdose Effects
- Signs and symptoms of overdose with GABA-P include reduced consciousness, depression/anxiety, confusional state, agitation, restlessness, seizures, and heart block.
Mode of Action
- Pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA).
Indications
- GABA-P is indicated for Neuropathic pain associated with diabetic peripheral neuropathy (DPN), Postherpetic neuralgia (PHN), Fibromyalgia, Neuropathic pain associated with spinal cord injury, and Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older.